Medpace Holdings (MEDP) Retained Earnings (2015 - 2026)
Medpace Holdings' (MEDP) quarterly Retained Earnings came in at -$511.4 million in Q2 2026, up 27.28% on a YoY basis from -$401.8 million in Q2 2025, and down 52.14% quarter-over-quarter from -$336.1 million in Q1 2026.
Analysis
Medpace Holdings (MEDP) Retained Earnings (2015 - 2026) Analysis & Trends
Medpace Holdings (MEDP) has reported Retained Earnings for 12 consecutive years, with -$511.4 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Retained Earnings rose 27.28% year-over-year to -$511.4 million; the trailing twelve-month figure through Jun 2026 stood at -$511.4 million (up 27.28% YoY), and the FY2025 full-year result was -$460.0 million, down 3020.0% from the prior year.
- Retained Earnings fell to -$511.4 million in Q2 2026 per MEDP's latest filing, from -$336.1 million in the prior quarter.
- Across five years, Retained Earnings topped out at $65.6 million in Q3 2024 and bottomed at -$703.2 million in Q2 2025.
- Historically, Retained Earnings has averaged -$310.2 million across 5 years, with a median of -$348.0 million in 2022.
- The sharpest annual moves came in 2024 and 2025: Retained Earnings soared 121.86% in 2024, then tumbled 3020.0% in 2025.
- Over 5 years, Retained Earnings stood at -$359.8 million in 2022, then soared by 38.4% to -$221.6 million in 2023, then jumped by 93.35% to -$14.7 million in 2024, then sank by 3020.0% to -$460.0 million in 2025, then slipped by 11.17% to -$511.4 million in 2026.
- According to Business Quant data, Retained Earnings over the past three periods registered -$511.4 million, -$336.1 million, and -$460.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 7.96 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | -511.37 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 2.30 Bn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 1.37 Bn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 2.14 Bn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | 1.71 Bn |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 6.70 Bn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | -81.50 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -106.74 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -357.34 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -511.37 Mn |
| Mar 31, 2026 | -336.11 Mn |
| Dec 31, 2025 | -459.98 Mn |
| Sep 30, 2025 | -596.24 Mn |
| Jun 30, 2025 | -703.22 Mn |
| Mar 31, 2025 | -269.72 Mn |
| Dec 31, 2024 | -14.74 Mn |
| Sep 30, 2024 | 65.64 Mn |
| Jun 30, 2024 | -30.79 Mn |
| Mar 31, 2024 | -119.14 Mn |
| Dec 31, 2023 | -221.65 Mn |
| Sep 30, 2023 | -300.20 Mn |
| Jun 30, 2023 | -371.02 Mn |
| Mar 31, 2023 | -408.10 Mn |
| Dec 31, 2022 | -359.83 Mn |
| Sep 30, 2022 | -380.12 Mn |
| Jun 30, 2022 | -446.14 Mn |
| Mar 31, 2022 | -120.81 Mn |
| Dec 31, 2021 | 234.98 Mn |
| Sep 30, 2021 | 184.95 Mn |